arthrocare corp (ARTC:NASDAQ GS)

Financial Statements for arthrocare corp (ARTC)

Currency in Millions of US Dollars	As of:	Dec 31 2009 Restated	Dec 31 2010 Reclassified	Dec 31 2011 Reclassified	Dec 31 2012	4 Year Trend
Revenues		324.1	355.4	354.9	368.5
TOTAL REVENUES		324.1	355.4	354.9	368.5
Cost of Goods Sold		90.9	110.8	102.9	108.0
GROSS PROFIT		233.2	244.6	252.0	260.5
Selling General & Admin Expenses, Total		192.6	143.4	141.7	149.3
R&D Expenses		35.2	35.8	27.5	32.1
Depreciation & Amortization, Total		5.3	5.2	5.3	4.9
OTHER OPERATING EXPENSES, TOTAL		233.1	184.5	174.5	186.3
OPERATING INCOME		0.1	60.2	77.5	74.2
Interest Expense		-3.8	--	--	--
Interest and Investment Income		--	0.2	0.0	0.7
Other Non-Operating Expenses, Total		1.5	-10.0	-82.2	-11.9
Other Non-Operating Income (Expenses)		0.3	-6.7	-81.4	-11.7
Merger & Restructuring Charges		--	--	-12.1	0.8
EBT, INCLUDING UNUSUAL ITEMS		-2.2	50.4	-16.8	63.7
Income Tax Expense		3.1	12.9	-14.0	17.3
Earnings from Continuing Operations		-5.3	37.5	-2.8	46.4
EARNINGS FROM DISCOUNTINUED OPERATIONS		-0.5	-0.4	1.9	--
NET INCOME		-5.8	37.1	-0.9	46.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-33.8	27.8	-4.3	35.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-33.3	28.3	-6.2	35.4

Report Data Issue

To contact ARTHROCARE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.